Inter‐ and intra‐individual concentrations of direct oral anticoagulants: The KIDOAC study-Reference-Cited by-同舟云学术

Inter‐ and intra‐individual concentrations of direct oral anticoagulants: The KIDOAC study

Published:2021-11-04 Issue:1 Volume:20 Page:92-103
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J of Thrombosis Haemost

Author:

Toorop Myrthe M. A.¹^ORCID,Rein Nienke¹²^ORCID,Nierman Melchior C.³,Vermaas Helga W.⁴,Huisman Menno V.⁵,Meer Felix J. M.⁵,Cannegieter Suzanne C.¹⁵^ORCID,Lijfering Willem M.¹⁶^ORCID

Affiliation:

1. Department of Clinical Epidemiology Leiden University Medical Center Leiden the Netherlands

2. Department of Clinical Pharmacy and Toxicology Leiden University Medical Center Leiden the Netherlands

3. Thrombosis Service of Amsterdam (Atalmedial) Amsterdam the Netherlands

4. Thrombosis Service of the Hague (LabWest) The Hague the Netherlands

5. Division of Thrombosis and Hemostasis Leiden University Medical Center Leiden the Netherlands

6. Kennisinstituut van de Federatie Medisch Specialisten Utrecht the Netherlands

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.15563

Reference34 articles.

1. National Trends in Ambulatory Oral Anticoagulant Use

2. NOACs replace VKA as preferred oral anticoagulant among new patients: a drug utilization study in 560 pharmacies in The Netherlands

3. Dabigatran versus Warfarin in Patients with Atrial Fibrillation

4. Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

5. Apixaban versus Warfarin in Patients with Atrial Fibrillation

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of reduced DOAC doses in atrial fibrillation patients does not always lead to good anticoagulation levels and avoid adverse events;International Journal of Cardiology;2024-12

2. Apixaban plasma concentrations before and after catheter ablation for atrial fibrillation;PLOS ONE;2024-07-31

3. Proactive monitoring of drug–drug interactions between direct oral anticoagulants and small-molecule inhibitors in patients with non-small cell lung cancer;British Journal of Cancer;2024-06-11

4. Évaluation pharmaceutique des risques de prescription des anticoagulants oraux directs chez le patient atteint de cancer;Le Pharmacien Clinicien;2024-05

5. Thrombotic events associated with low baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study;Blood Advances;2024-04-10